Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses

mBio

Volumn 5, Issue 3, 2014, Pages

  Menachery, Vineet D ^a   Eisfeld, Amie J ^c,i   Schäfer, Alexandra ^a   Josset, Laurence ^d   Sims, Amy C ^a   Proll, Sean ^d   Fan, Shufang ^c,i   Li, Chengjun ^c,i   Neumann, Gabriele ^c,i   Tilton, Susan C ^e   Chang, Jean ^d   Gralinski, Lisa E ^a   Long, Casey ^a   Green, Richard ^d   Williams, Christopher M ^d   Weiss, Jeffrey ^d   Matzke, Melissa M ^e   Webb Robertson, Bobbie Jo ^a   Schepmoes, Athena A ^e   Shukla, Anil K ^e   Metz, Thomas O ^e   Smith, Richard D ^e   Waters, Katrina M ^e   Katze, Michael G ^d,f   Kawaoka, Yoshihiro ^c,g,h,i   Baric, Ralph S ^a,b   more..

^a AVR: Department of Epidemiology   (United States)

^b Depts Med Microbiol and Immunol   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF TOKYO   (Japan)

^h JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

ⁱ UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; INTERFERON STIMULATED GENE FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; HISTONE; INS1 PROTEIN, INFLUENZA VIRUS; PROTEIN BINDING; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; CORONAVIRUS; CORONAVIRUS INFECTION; DATA ANALYSIS; DOWN REGULATION; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; HISTONE MODIFICATION; IMMUNOREGULATION; INFLUENZA A (H1N1); INFLUENZA A (H5N1); INFLUENZA VIRUS; INNATE IMMUNITY; ISG GENE; MIDDLE EAST RESPIRATORY SYNDROME; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; SEVERE ACUTE RESPIRATORY SYNDROME; SPECIES COMPARISON; TRANSCRIPTOMICS; VIRUS CELL INTERACTION; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; BIOLOGICAL MODEL; CELL LINE; CLUSTER ANALYSIS; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1; METABOLISM; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PHYSIOLOGY; SARS CORONAVIRUS; VIROLOGY;

ANIMALS; CELL LINE; CLUSTER ANALYSIS; CORONAVIRUS; CORONAVIRUS INFECTIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HISTONES; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; INTERFERON TYPE I; INTERFERONS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEOMICS; SARS VIRUS; TRANSCRIPTION FACTORS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84904015653     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01174-14     Document Type: Article

References (54)

1. Perlman S. 1998. Pathogenesis of coronavirus-induced infections. Review of pathological and immunological aspects. Adv. Exp. Med. Biol. 440: 503-513.
2. Gillim-Ross L, Subbarao K. 2006. Emerging respiratory viruses: challenges and vaccine strategies. Clin. Microbiol. Rev. 19: 614-636. http://dx. doi. org/10. 1128/CMR. 00005-06.
3. van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus AD, Haagmans BL, Gorbalenya AE, Snijder EJ, Fouchier RA. 2012. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 3(6): e00473-12. http://dx. doi. org/10. 1128/mBio. 00473-12.
4. Ng WF, To KF, Lam WW, Ng TK, Lee KC. 2006. The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1-a review. Hum. Pathol. 37: 381-390. http://dx. doi. org/10. 1016/j. humpath. 2006. 01. 015.
5. Li C, Bankhead A, Eisfeld AJ, Hatta Y, Jeng S, Chang JH, Aicher LD, Proll S, Ellis AL, Law GL, Waters KM, Neumann G, Katze MG, McWeeney S, Kawaoka Y. 2011. Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus. J. Virol. 85: 10955-10967. http://dx. doi. org/10. 1128/JVI. 05792-11.
6. Josset L, Menachery VD, Gralinski LE, Agnihothram S, Sova P, Carter VS, Yount BL, Graham RL, Baric RS, Katze MG. 2013. Cell host response to infection with novel human coronavirusEMCpredicts potential antivirals and important differences with SARS coronavirus. mBio 4(3): e00165-00113. http://dx. doi. org/10. 1128/mBio. 00165-13.
7. Sims AC, Tilton SC, Menachery VD, Gralinski LE, Schäfer A, Matzke MM, Webb-Robertson BJ, Chang J, Luna ML, Long CE, Shukla AK, Bankhead AR, Burkett SE, Zornetzer G, Tseng CT, Metz TO, Pickles R, McWeeney S, Smith RD, Katze MG, Waters KM, Baric RS. 2013. Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells. J. Virol. 87: 3885-3902. http://dx. doi. org/10. 1128/JVI. 02520-12.
8. Menachery VD, Baric RS. 2013. Bugs in the system. Immunol. Rev. 255: 256-274. http://dx. doi. org/10. 1111/imr. 12092.
9. Katze MG, He Y, Gale M, Jr. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2: 675-687. http://dx. doi. org/10. 1038/nri888.
10. García-Sastre A. 2011. Induction and evasion of type I interferon responses by influenza viruses. Virus Res. 162: 12-18. http://dx. doi. org/10. 1016/j. virusres. 2011. 10. 017.
11. Totura AL, Baric RS. 2012. SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr. Opin. Virol. 2: 264-275. http://dx. doi. org/10. 1016/j. coviro. 2012. 04. 004.
12. Rockx B, Baas T, Zornetzer GA, Haagmans B, Sheahan T, Frieman M, Dyer MD, Teal TH, Proll S, van den Brand J, Baric R, Katze MG. 2009. Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. J. Virol. 83: 7062-7074. http://dx. doi. org/10. 1128/JVI. 00127-09.
13. Mi Z, Ma Y, Tong Y. 2012. Avian influenza virus H5N1 induces rapid interferon-beta production but shows more potent inhibition to retinoic acid-inducible gene I expression than H1N1 in vitro. Virol. J. 9: 145. http://dx. doi. org/10. 1186/1743-422X-9-145.
14. Zielecki F, Semmler I, Kalthoff D, Voss D, Mauel S, Gruber AD, Beer M, Wolff T. 2010. Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein. J. Virol. 84: 10708-10718. http://dx. doi. org/10. 1128/JVI. 00610-10.
15. Chan RW, Chan MC, Agnihothram S, Chan LL, Kuok DI, Fong JH, Guan Y, Poon LL, Baric RS, Nicholls JM, Peiris JS. 2013. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J. Virol. 87: 6604-6614. http://dx. doi. org/10. 1128/JVI. 00009-13.
16. Zielecki F, Weber M, Eickmann M, Spiegelberg L, Zaki AM, Matrosovich M, Becker S, Weber F. 2013. Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J. Virol. 87: 5300-5304. http://dx. doi. org/10. 1128/JVI. 03496-12.
17. Hale BG, Randall RE, Ortín J, Jackson D. 2008. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89: 2359-2376. http://dx. doi. org/10. 1099/vir. 0. 2008/004606-0.
18. Decker T, Kovarik P, Meinke A. 1997. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon Cytokine Res. 17: 121-134. http://dx. doi. org/10. 1089/jir. 1997. 17. 121.
19. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. 2007. High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837. http://dx. doi. org/10. 1016/j. cell. 2007. 05. 009.
20. Bonham AJ, Wenta N, Osslund LM, Prussin AJ, Vinkemeier U, Reich NO. 2013. STAT1: DNA sequence-dependent binding modulation by phosphorylation, protein: protein interactions and small-molecule inhibition. Nucleic Acids Res. 41: 754-763. http://dx. doi. org/10. 1093/nar/gks1085.
21. Alfonso R, Lutz T, Rodriguez A, Chavez JP, Rodriguez P, Gutierrez S, Nieto A. 2011. CHD6 chromatin remodeler is a negative modulator of influenza virus replication that relocates to inactive chromatin upon infection. Cell. Microbiol. 13: 1894-1906. http://dx. doi. org/10. 1111/j. 1462-5822. 2011. 01679. x.
22. Garcia-Robles I, Akarsu H, Müller CW, Ruigrok RW, Baudin F. 2005. Interaction of influenza virus proteins with nucleosomes. Virology 332: 329-336. http://dx. doi. org/10. 1016/j. virol. 2004. 09. 036.
23. Zhirnov OP, Klenk HD. 1997. Histones as a target for influenza virus matrix protein M1. Virology 235: 302-310. http://dx. doi. org/10. 1006/viro. 1997. 8700.
24. Marazzi I, Ho JS, Kim J, Manicassamy B, Dewell S, Albrecht RA, Seibert CW, Schaefer U, Jeffrey KL, Prinjha RK, Lee K, García-Sastre A, Roeder RG, Tarakhovsky A. 2012. Suppression of the antiviral response by an influenza histone mimic. Nature 483: 428-433. http://dx. doi. org/10. 1038/nature10892.
25. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128: 693-705. http://dx. doi. org/10. 1016/j. cell. 2007. 02. 005.
26. Cloos PA, Christensen J, Agger K, Helin K. 2008. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev. 22: 1115-1140. http://dx. doi. org/10. 1101/gad. 1652908.
27. Hargreaves DC, Horng T, Medzhitov R. 2009. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138: 129-145. http://dx. doi. org/10. 1016/j. cell. 2009. 05. 047.
28. Yu H, Zhu S, Zhou B, Xue H, Han JD. 2008. Inferring causal relationships among different histone modifications and gene expression. Genome Res. 18: 1314-1324. http://dx. doi. org/10. 1101/gr. 073080. 107.
29. Schat KA, Bingham J, Butler JM, Chen LM, Lowther S, Crowley TM, Moore RJ, Donis RO, Lowenthal JW. 2012. Role of position 627 of PB2 and the multibasic cleavage site of the hemagglutinin in the virulence of H5N1 avian influenza virus in chickens and ducks. PLoS One 7: e30960. http://dx. doi. org/10. 1371/journal. pone. 0030960.
30. Ozawa M, Basnet S, Burley LM, Neumann G, Hatta M, Kawaoka Y. 2011. Impact of amino acid mutations in PB2, PB1-F2, and NS1 on the replication and pathogenicity of pandemic (H1N1) 2009 influenza viruses. J. Virol. 85: 4596-4601. http://dx. doi. org/10. 1128/JVI. 00029-11.
31. Varga ZT, Grant A, Manicassamy B, Palese P. 2012. Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J. Virol. 86: 8359-8366. http://dx. doi. org/10. 1128/JVI. 01122-12.
32. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE, Hill DE, Regev A, Hacohen N. 2009. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139: 1255-1267. http://dx. doi. org/10. 1016/j. cell. 2009. 12. 018.
33. Billharz R, Zeng H, Proll SC, Korth MJ, Lederer S, Albrecht R, Goodman AG, Rosenzweig E, Tumpey TM, García-Sastre A, Katze MG. 2009. The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways. J. Virol. 83: 10557-10570. http://dx. doi. org/10. 1128/JVI. 00330-09.
34. Anonymous. 2010. Epigenetic control of the immune system: histone demethylation as a target for drug discovery. Drug Discov. Today Technol. 7: e1-e94. http://dx. doi. org/10. 2174/157016310791162721.
35. Ishii M, Wen H, Corsa CA, Liu T, Coelho AL, Allen RM, Carson WF, Cavassani KA, Li X, Lukacs NW, Hogaboam CM, Dou Y, Kunkel SL. 2009. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 114: 3244-3254. http://dx. doi. org/10. 1182/blood-2009-04-217620.
36. Fang TC, Schaefer U, Mecklenbrauker I, Stienen A, Dewell S, Chen MS, Rioja I, Parravicini V, Prinjha RK, Chandwani R, MacDonald MR, Lee K, Rice CM, Tarakhovsky A. 2012. Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response. J. Exp. Med. 209: 661-669. http://dx. doi. org/10. 1084/jem. 20112343.
37. Cedar H, Bergman Y. 2009. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10: 295-304. http://dx. doi. org/10. 1038/nrg2540.
38. Kaelin WG, Jr, McKnight SL. 2013. Influence of metabolism on epigenetics and disease. Cell 153: 56-69. http://dx. doi. org/10. 1016/j. cell. 2013. 03. 004.
39. Fonseca GJ, Thillainadesan G, Yousef AF, Ablack JN, Mossman KL, Torchia J, Mymryk JS. 2012. Adenovirus evasion of interferon-mediated innate immunity by direct antagonism of a cellular histone posttranslational modification. Cell Host Microbe 11: 597-606. http://dx. doi. org/10. 1016/j. chom. 2012. 05. 005.
40. Gómez-Díaz E, Jordà M, Peinado MA, Rivero A. 2012. Epigenetics of host-pathogen interactions: the road ahead and the road behind. PLoS Pathog. 8: e1003007. http://dx. doi. org/10. 1371/journal. ppat. 1003007.
41. Woo YH, Li WH. 2012. Evolutionary conservation of histone modifications in mammals. Mol. Biol. Evol. 29: 1757-1767. http://dx. doi. org/10. 1093/molbev/mss022.
42. Kim MJ, Latham AG, Krug RM. 2002. Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc. Natl. Acad. Sci. U. S. A. 99: 10096-10101. http://dx. doi. org/10. 1073/pnas. 152327499.
43. Chen Z, Krug RM. 2000. Selective nuclear export of viral mRNAs in influenza-virus-infected cells. Trends Microbiol. 8: 376-383. http://dx. doi. org/10. 1016/S0966-842X(00)01794-7.
44. Li Y, Chan EY, Li J, Ni C, Peng X, Rosenzweig E, Tumpey TM, Katze MG. 2010. MicroRNA expression and virulence in pandemic influenza virus-infected mice. J. Virol. 84: 3023-3032. http://dx. doi. org/10. 1128/JVI. 02203-09.
45. Noah DL, Twu KY, Krug RM. 2003. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3= end processing of cellular pre-mRNAS. Virology 307: 386-395. http://dx. doi. org/10. 1016/S0042-6822(02)00127-7.
46. Chen Z, Li Y, Krug RM. 1999. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3=-end processing machinery. EMBO J. 18: 2273-2283. http://dx. doi. org/10. 1093/emboj/18. 8. 2273.
47. Satterly N, Tsai PL, van Deursen J, Nussenzveig DR, Wang Y, Faria PA, Levay A, Levy DE, Fontoura BM. 2007. Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc. Natl. Acad. Sci. U. S. A. 104: 1853-1858. http://dx. doi. org/10. 1073/pnas. 0610977104.
48. Korth MJ, Tchitchek N, Benecke AG, Katze MG. 2013. Systems approaches to influenza-virus host interactions and the pathogenesis of highly virulent and pandemic viruses. Semin. Immunol. 25: 228-239. http://dx. doi. org/10. 1016/j. smim. 2012. 11. 001.
49. Uraki R, Kiso M, Shinya K, Goto H, Takano R, Iwatsuki-Horimoto K, Takahashi K, Daniels RS, Hungnes O, Watanabe T, Kawaoka Y. 2013. Virulence determinants of pandemic A(H1N1)2009 influenza virus in a mouse model. J. Virol. 87: 2226-2233. http://dx. doi. org/10. 1128/JVI. 01565-12.
50. Niemeyer D, Zillinger T, Muth D, Zielecki F, Horvath G, Suliman T, Barchet W, Weber F, Drosten C, Müller MA. 2013. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J. Virol. 87: 12489-12495. http://dx. doi. org/10. 1128/JVI. 01845-13.
51. Matthews KL, Coleman CM, van der Meer Y, Snijder EJ, Frieman MB. 2014. The ORF4b-encoded accessory proteins of MERS-coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signaling. J. Gen. Virol. 95: 874-882. http://dx. doi. org/10. 1099/vir. 0. 062059-0.
52. Scobey T, Yount BL, Sims AC, Donaldson EF, Agnihothram SS, Menachery VD, Graham RL, Swanstrom J, Bove PF, Kim JD, Grego S, Randell SH, Baric RS. 2013. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. U. S. A. 110: 16157-16162. http://dx. doi. org/10. 1073/pnas. 1311542110.
53. Yount B, Curtis KM, Fritz EA, Hensley LE, Jahrling PB, Prentice E, Denison MR, Geisbert TW, Baric RS. 2003. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. U. S. A. 100: 12995-13000. http://dx. doi. org/10. 1073/pnas. 1735582100.
54. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, Hughes M, Perez DR, Donis R, Hoffmann E, Hobom G, Kawaoka Y. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. U. S. A. 96: 9345-9350. http://dx. doi. org/10. 1073/pnas. 96. 16. 9345.